Peptide Therapeutics intermediate
Degarelix - CS21 (NCT00106437)
Clinical trial of degarelix for prostate cancer. This peptide or oligopeptide is studied for its biological activity, structure-activity relationships, and p...
By Encyclopeptide Editorial | 1 min read
degarelix-cs21-nct00106437 peptide research
Overview
Clinical trial of degarelix for prostate cancer.
Clinical Significance
This topic has important implications for peptide research and clinical applications.
References
- Encyclopeptide Database. “Degarelix - CS21 (NCT00106437)” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Degarelix - CS21 (NCT00106437) with interactive quizzes on Wikipept.
Take a Quiz on Wikipept